DACH Pharmacy E-commerce: Revenue Trajectory and 2026 Projections

The DACH region’s pharmacy e-commerce sector continues its expansion, driven by evolving consumer preferences and digital health infrastructure advancements. This analysis provides a data-driven overview of the market’s current state and projects its revenue trajectory through 2026, highlighting key growth indicators and market dynamics across Germany, Austria, and Switzerland.

Market Evolution and Revenue Forecast for the DACH Region

The online pharmacy market in the DACH region has demonstrated consistent growth, establishing itself as a significant channel for pharmaceutical and health-related products. This expansion is underpinned by increasing digital literacy among consumers and the convenience offered by e-commerce platforms.

Data indicates that the total online pharmacy market revenue for the DACH region reached approximately €4.65 billion in 2023. Projections for the coming years suggest continued double-digit growth rates, albeit with some moderation as the market matures and integrates new regulatory frameworks. The primary revenue drivers remain over-the-counter (OTC) medications, dietary supplements, and beauty/wellness products. However, the anticipated impact of the elektronisches Rezept (e-Rezept) in Germany is expected to significantly influence prescription medication sales through digital channels.

The following table presents the historical and projected revenue for the DACH online pharmacy market, along with annual growth rates and the online penetration of the total pharmacy market. These figures represent the aggregate performance across Germany, Austria, and Switzerland.

These projections indicate that by 2026, the DACH online pharmacy market is expected to generate approximately €6.70 billion in revenue, representing an online penetration rate of 14.5% of the total pharmacy market. The slight acceleration in growth from 2025 to 2026 is primarily attributed to the increasing adoption and functionality of the e-Rezept system in Germany, which is expected to unlock a larger share of the prescription drug market for online retailers.

German Market Dynamics and e-Rezept Impact

Germany represents the largest component of the DACH online pharmacy market, consistently accounting for over 85% of the region’s total online pharmacy revenue. This dominance is due to its significant population, established e-commerce infrastructure, and a relatively permissive regulatory environment for online OTC sales compared to some other European nations.

The introduction and progressive rollout of the elektronisches Rezept (e-Rezept) in Germany stands as the most transformative regulatory development impacting the online pharmacy sector. While initial adoption rates were modest, the mandatory introduction of the e-Rezept for prescription medications as of January 1, 2024, has initiated a fundamental shift. Prior to this, online sales of prescription drugs were limited due to the physical prescription requirement.

Data from Gematik GmbH, the national agency for digital medicine, indicates that the number of redeemed e-Rezept prescriptions has steadily increased throughout 2023 and into 2024. As of Q1 2024, the monthly redemption rate via pharmacy apps and online services has shown a notable uptick, moving from less than 1% of all prescriptions in early 2023 to over 10% by mid-2024 for digitally capable prescriptions. This trend is expected to continue, reaching an estimated 30-40% online redemption rate for e-Rezept prescriptions by 2026.

The online penetration for OTC products in Germany has already reached approximately 16% in 2023, driven by competitive pricing and convenience. For prescription medications, this penetration was historically negligible for distance selling. However, with the e-Rezept, online pharmacies are now positioned to capture a share of the €50+ billion German prescription drug market. Forecasts suggest that the online share of prescription drug sales could reach 5-8% by 2026, a substantial increase from its near-zero baseline. This translates into billions of Euros in new addressable market for online pharmacies.

Austrian and Swiss Online Pharmacy Landscape

While smaller in absolute terms compared to Germany, the online pharmacy markets in Austria and Switzerland exhibit distinct characteristics shaped by their respective regulatory frameworks and consumer behaviors.

Austria: The Austrian online pharmacy market is more restrictive than Germany’s, particularly concerning prescription medications. Online sales of prescription-only drugs are generally prohibited, with a strong emphasis on local brick-and-mortar pharmacies. Consequently, the Austrian online pharmacy market is predominantly focused on OTC products, dietary supplements, and health-related non-pharmaceuticals. In 2023, the Austrian online pharmacy market generated an estimated €350 million in revenue, representing approximately 7.5% of the total DACH online pharmacy market. Growth rates have been steady, averaging around 8-10% annually, driven by consumer demand for convenience and a broader product selection than typically available in smaller local pharmacies. By 2026, the Austrian market is projected to approach €450 million. Regulatory changes permitting online prescription fulfillment are not anticipated within the forecast period, thus maintaining the focus on OTC and ancillary health products.

Switzerland: Switzerland’s pharmacy market is characterized by a hybrid model, with a mix of traditional pharmacies, drugstores (Drogerien), and a growing presence of online retailers. The regulatory landscape for online pharmacies is complex, with cantonal variations and strict rules regarding prescription drug sales. While some online pharmacies with physical presences offer prescription services, distance selling of prescription drugs to new patients without prior consultation or an existing relationship with a local pharmacy is generally limited. The Swiss online pharmacy market generated an estimated €200 million in 2023, accounting for approximately 4.3% of the DACH total. Growth is largely driven by OTC products, health and beauty items, and the convenience factor for consumers in a country with high digital adoption. Annual growth rates have been in the 7-9% range. By 2026, the Swiss online pharmacy market is forecast to reach approximately €250 million. The introduction of digital prescriptions (e-Rezept analogue) is in early stages of discussion and pilot projects, but widespread implementation and its impact on online sales are not expected to materialize significantly within the 2026 forecast horizon.

Key Market Players and Competitive Structure

The DACH online pharmacy market is characterized by a degree of concentration, with a few major players holding substantial market shares. These entities have invested heavily in logistics, technology platforms, and marketing to establish their positions.

Leading market participants include Shop Apotheke Europe (operating under various brands including Shop Apotheke and Redcare Pharmacy) and the Zur Rose Group (operating primarily as DocMorris in Germany). These two companies collectively hold a significant portion of the online pharmacy revenue in the DACH region.

• Shop Apotheke Europe (Redcare Pharmacy): This company has consistently been a top performer in the DACH region, particularly strong in Germany. Its market share in the German online pharmacy segment for OTC and non-pharmaceutical products is estimated to be over 30%. The company has expanded its portfolio beyond traditional pharmacy products into beauty, wellness, and health services.
• Zur Rose Group (DocMorris): Following its strategic focus on Germany and the e-Rezept, the Zur Rose Group rebranded its German activities under the DocMorris name. It has a long-standing brand presence and has been a vocal proponent and early adopter of the e-Rezept. DocMorris holds a substantial market share, estimated to be in the 20-25% range in the German online pharmacy market for OTC and non-pharmaceuticals. Its strategic positioning is heavily geared towards capturing a significant share of the e-Rezept market.
• Other Players: The remainder of the market is fragmented among smaller online pharmacies, traditional brick-and-mortar pharmacies establishing online channels, and general e-commerce platforms extending into health products. Examples include Medpex (part of the Zur Rose Group), Aponeo, and various regional players. The entry of traditional pharmacy cooperatives and chains into the online space is also contributing to competition.

The competitive landscape is expected to intensify with the increasing relevance of the e-Rezept. Large online pharmacies with established logistics and digital infrastructure are positioned to benefit, while smaller players may struggle to compete on scale and fulfillment capabilities for prescription medications.

Consumer Adoption and Digital Channel Shift

Consumer behavior in the DACH region is progressively shifting towards digital channels for health-related purchases. This trend is driven by several factors:

• Convenience: The ability to order medications and health products 24/7, with home delivery, appeals to a growing segment of the population, particularly in urban areas and for individuals with limited mobility.
• Price Transparency: Online platforms often allow for easier price comparison, which can lead to cost savings for consumers, especially for non-prescription items where pricing is not fixed.
• Product Assortment: Online pharmacies typically offer a wider range of products than a local brick-and-mortar pharmacy, including niche health products, supplements, and international brands.
• Digital Literacy: The overall increase in digital literacy and comfort with online transactions across all age groups in the DACH region contributes to higher adoption rates for online pharmacy services.
• Telemedicine Integration: The increasing acceptance and integration of telemedicine services are creating a seamless pathway from online consultation to digital prescription and subsequent online fulfillment, particularly in Germany.

The online penetration rate for OTC products in Germany reached approximately 16% in 2023, up from around 10% in 2019. This reflects a clear channel shift for non-prescription items. For prescription medications, the e-Rezept is the primary catalyst for online adoption. Initial data from early 2024 indicates that a significant portion of e-Rezept users are opting for digital redemption methods, including online pharmacies, rather than solely relying on physical pharmacy visits. This suggests a strong consumer inclination towards digital solutions when available and facilitated by regulation. The ease of use and perceived efficiency of the e-Rezept system are critical factors influencing this shift.

Frequently Asked Questions

What is the projected revenue for DACH pharmacy e-commerce in 2026? The DACH online pharmacy market is projected to reach approximately €6.70 billion in revenue by 2026. This represents an annual growth rate of 12.6% for that year, contributing to an online penetration rate of 14.5% of the total pharmacy market.

What is the forecasted online penetration rate for DACH pharmacies by 2026? By 2026, the online penetration of the total pharmacy market in the DACH region is forecast to reach 14.5%. This indicates a continued shift towards digital channels for pharmaceutical and health-related product purchases across Germany, Austria, and Switzerland.

How will the e-Rezept impact German online pharmacy sales by 2026? The e-Rezept is expected to significantly increase the online share of prescription drug sales in Germany, potentially reaching 5-8% by 2026. This is supported by projections of a 30-40% online redemption rate for e-Rezept prescriptions by the same year, unlocking a substantial new market for online pharmacies.

What are the revenue forecasts for Austrian and Swiss online pharmacy markets in 2026? The Austrian online pharmacy market is projected to approach €450 million in revenue by 2026, primarily driven by OTC products due to regulatory restrictions on prescription sales. For Switzerland, the online pharmacy market is forecast to reach approximately €250 million by 2026, also focusing on OTC and health/beauty items.

Who are the dominant players in the DACH online pharmacy market? Shop Apotheke Europe (Redcare Pharmacy) and the Zur Rose Group (DocMorris) are the dominant players in the DACH online pharmacy market. Shop Apotheke Europe holds an estimated market share of over 30% in the German online pharmacy segment for OTC products, while DocMorris is estimated to be in the 20-25% range.

For deeper strategic analysis, see our

By 2026, the DACH online pharmacy market is projected to reach approximately €6.70 billion in revenue, representing a 14.5% online penetration of the total pharmacy market. This trajectory is significantly shaped by the increasing adoption of the e-Rezept in Germany, which is poised to drive substantial growth in online prescription medication sales.